1-2 of 2
Ulrich von Grünhagen, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subanalysis of the StiL NHL 1–2003 Study: Achievement of Complete Response with Bendamustine-Rituximab (B-R) and CHOP-R in the First-Line Treatment of Indolent and Mantle Cell Lymphomas Results in Superior Survival Compared to Partial Response.

Mathias J. Rummel, MD, Norbert Niederle, Georg Maschmeyer, MD, G.-Andre Banat, MD, PhD, MBA, Ulrich von Grünhagen, MD, PhD, Chrisoph Losem, MD, PhD, Dorothea Kofahl-Krause, Gerhard Heil, MD, Manfred Welslau, Christina Balser, Ulrich Kaiser, MD, Eckhart Weidmann, Heinz A. Duerk, MD, PhD, Harald Ballo, Martina Beate Stauch, MD, Fritz Roller, Juergen Barth, Axel Hinke, Alexander C. Burchardt, MD, Wolfram Brugger
Journal: Blood
Blood (2012) 120 (21): 2724.
https://doi.org/10.1182/blood.V120.21.2724.2724
Published: 2012
Journal Articles

No Elevated Rates of Treatment-Related Myelodysplastic Syndromes and Second Solid Tumors Following Therapy with Bendamustine Compared with Other Anti-Lymphoma Regimes for Low-Grade Non-Hodgkin's Lymphoma

Mathias J Rummel, MD, PhD, Aline Tenzer, Norbert Niederle, MD, PhD, Chrisoph Losem, MD, PhD, Christina Balser, MD, PhD, Harald-E. Balló, MD, PhD, Manfred Welslau, MD, PhD, Ulrich von Grünhagen, MD, PhD, Wolfram Brugger, MD, PhD, Georg Maschmeyer, MD, PhD, Axel C. Matzdorff, MD, PhD, Arnold Ganser, MD, PhD, Eckhart Weidmann, MD, PhD, Gerhard Heil, MD, PhD, Axel Hinke, Jürgen Barth
Journal: Blood
Blood (2010) 116 (21): 3090.
https://doi.org/10.1182/blood.V116.21.3090.3090
Published: 2010